Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance coverage has fueled a risky but growing “gray” market for purchasing active ...

GLP-1s - which mimic the effects of the hormone that stimulates insulin release, suppressing glucagon, and slowing gastric ...

President Donald Trump has promised to reduce American drug prices by mathematically impossible figures of up to “1400 percent.” Speaking during a White House event attended by Republican members of ...